{"schema":"rootz.ai/filing-signals/v1","query":{"ticker":"NGVT","limit":50},"count":50,"signals":[{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":32,"context":"consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) exceeds $5,000,000. Material Adverse Effect means a circumstance or condition that has materially adversely affected or would reasonably be expected to materially adversely affect (a) the business, assets, operations or financial condition of","filed_date":"2026-03-30","accession":"0001104659-26-036423","full_text":"https://origin.rootz.global/static/filing/0001104659-26-036423.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":19,"context":"onsBoard leadership role in CEO and executive succession planningRobust enterprise risk management program that includes Board oversight of key risk areasBoard oversight of sustainability matters and cybersecurity risk (primarily through the Sustainability and Safety Committee)Annual Sustainability Report containing measurable sustainability goalsComprehensive new director orientationPolicy prohibiting","filed_date":"2026-03-17","accession":"0001104659-26-029507","full_text":"https://origin.rootz.global/static/filing/0001104659-26-029507.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":26,"context":"OF BUSINESSAt the Annual Meeting, stockholders will be asked to act on the following items:Elect nine (9) director nominees;Approve, on a non-binding, advisory basis, the compensation of the Companys named executive officers;Ratify the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for 2026;Approve amendment to increase share authorization under the Ingevity Corpo","filed_date":"2026-03-17","accession":"0001104659-26-029507","full_text":"https://origin.rootz.global/static/filing/0001104659-26-029507.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":21,"context":"continued operations for all periods presented. The sale was completed on January 1, 2026.PC Repositioning Status and Charges To DateWe have substantially completed all activities associated with the restructuring program and expect the plan to be completed in 2026. The PC Repositioning Actions restructuring program is expected to result in total charges of approximately $370 million, consisting primarily of:~$255 mil","filed_date":"2026-02-26","accession":"0001653477-26-000014","full_text":"https://origin.rootz.global/static/filing/0001653477-26-000014.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_concentration","strength":100,"match_count":2,"context":"of various jurisdictions within North America, South America, Europe, China, Brazil and India, and revenue either directly or indirectly attributable to such government spending continues to remain a significant portion of our revenues. Government business is, in general, subject to special risks and challenges, including: delays in funding and uncertainty regarding the allocation of funds to federal, state and local agencies; del","filed_date":"2026-02-26","accession":"0001653477-26-000014","full_text":"https://origin.rootz.global/static/filing/0001653477-26-000014.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":39,"context":"aterial effects that compliance with these regulations may have on Ingevity's capital expenditures, earnings, or competitive position, but we currently anticipate that such compliance will not have a material adverse effect on any of the foregoing. Environmental and other regulations and related legal proceedings have the potential to involve significant costs and liability for Ingevity.Intellectual PropertyProtection o","filed_date":"2026-02-26","accession":"0001653477-26-000014","full_text":"https://origin.rootz.global/static/filing/0001653477-26-000014.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":17,"context":"repositioning, consisting of approximately $250.0 million in asset-related charges, approximately $25.0 million in severance and other employee-related costs, and approximately $75.0 million in other restructuring costs including decommissioning, dismantling and removal charges, and contract termination costs. We expect approximately $250.0 million of the total charges to be non-cash and $100.0 million to be settled","filed_date":"2025-02-19","accession":"0001653477-25-000015","full_text":"https://origin.rootz.global/static/filing/0001653477-25-000015.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":43,"context":"effects that compliance with these regulations may have upon the capital expenditures, earnings, or competitive position of Ingevity, but we currently anticipate that such compliance will not have a material adverse effect on any of the foregoing. Environmental and other regulations and related legal proceedings have the potential to involve significant costs and liability for Ingevity.Intellectual PropertyProtection o","filed_date":"2025-02-19","accession":"0001653477-25-000015","full_text":"https://origin.rootz.global/static/filing/0001653477-25-000015.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":12,"context":"presenting 819,898 and 1,269,373 shares of our common stock at a weighted average cost per share of $70.87 and $71.93, respectively. Note 11: Restructuring and Other (Income) Charges, netDetail on therestructuring charges and other (income) charges, net, is provided below. | | | Three Months Ended June 30, | Six Months Ended June 30, | | | In millions | 2024 | 2023 | 2024 | 2023 | | | | | | | | | Restructuring charges","filed_date":"2024-08-01","accession":"0001653477-24-000082","full_text":"https://origin.rootz.global/static/filing/0001653477-24-000082.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":14,"context":"verage cost per share of zero and $73.86, respectively. At March31, 2024,$353.4 million remained unused under the 2022 Authorization.Note 11: Restructuring and Other (Income) Charges, netDetail on therestructuring charges and other (income) charges, net, is provided below. | | | Three Months Ended March 31, | | | In millions | 2024 | 2023 | | | | | | | | | Restructuring charges | $ | 62.3 | $ | 3.1 | | | | | | | | | O","filed_date":"2024-05-02","accession":"0001653477-24-000058","full_text":"https://origin.rootz.global/static/filing/0001653477-24-000058.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":19,"context":"e self-evaluations Annual director evaluations Board leadership role in CEO and executive succession planning Robust risk management program that includes Board oversight of key risk areas, including cybersecurity Board oversight of environmental and sustainability matters (primarily through the Sustainability and Safety Committee) Annual Sustainability Report containing measurable sustainability goals","filed_date":"2024-03-11","accession":"0001308179-24-000092","full_text":"https://origin.rootz.global/static/filing/0001308179-24-000092.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":13,"context":"ked to act on the following items: |  |  |  Elect the nine (9) director nominees named in the proxy statement; | | |  |  |  Approve, on a non-binding, advisory basis, the compensation of the Companys named executive officers; | | |  |  |  Ratify the appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for 2024; | | |  |  |  Approve the amendment to the Companys Certific","filed_date":"2024-03-11","accession":"0001308179-24-000092","full_text":"https://origin.rootz.global/static/filing/0001308179-24-000092.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":18,"context":"d Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. Recent DevelopmentsRestructuring ChargesPerformance Chemicals RepositioningThroughout 2023 we initiated several measures across the organization to pursue greater cost efficiency which included a reorganization to streamline certain functio","filed_date":"2024-02-22","accession":"0001653477-24-000009","full_text":"https://origin.rootz.global/static/filing/0001653477-24-000009.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":45,"context":"effects that compliance with these regulations may have upon the capital expenditures, earnings, or competitive position of Ingevity, but we currently anticipate that such compliance will not have a material adverse effect on any of the foregoing. Environmental and other regulations and related legal proceedings have the potential to involve significant costs and liability for Ingevity. Intellectual Property Intellectu","filed_date":"2024-02-22","accession":"0001653477-24-000009","full_text":"https://origin.rootz.global/static/filing/0001653477-24-000009.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"ai_adoption","strength":100,"match_count":14,"context":"oyees salary. Generally, all U.S. employees of Ingevity below grade 21 who have been employed for at least thirty days are eligible to participate in the ESPP. The administrator may, prior to the enrollment period for an offering, make determinations about which other employees shall be excluded from participating, such as employees who have been employed less than two years (or a lesser period), emp","filed_date":"2023-03-10","accession":"0001308179-23-000122","full_text":"https://origin.rootz.global/static/filing/0001308179-23-000122.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":15,"context":"am Annual Board and committee self-evaluations Board leadership role in CEO and executive succession planning Robust risk management program that includes Board oversight of key risk areas, including cybersecurity Board oversight of environmental and sustainability matters (primarily through the Sustainability and Safety Committee) Annual Sustainability Report containing measurable sustainability goals","filed_date":"2023-03-10","accession":"0001308179-23-000122","full_text":"https://origin.rootz.global/static/filing/0001308179-23-000122.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":28,"context":"tockholders will be asked to act on the following items: Elect the ten (10) director nominees named in the proxy statement; Approve, on a non-binding, advisory basis, the compensation of the Companys named executive officers;  Approve, on a non-binding, advisory basis, the frequency of advisory votes to approve the Companys named executive officer compensation; Ratify the appointment of PricewaterhouseCoopers LLP as the","filed_date":"2023-03-10","accession":"0001308179-23-000122","full_text":"https://origin.rootz.global/static/filing/0001308179-23-000122.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":20,"context":"effects that compliance with these regulations may have upon the capital expenditures, earnings, or competitive position of Ingevity, but we currently anticipate that such compliance will not have a material adverse effect on any of the foregoing. Environmental and other regulations and related legal proceedings have the potential to involve significant costs and liability for Ingevity. Intellectual Property Intellectu","filed_date":"2023-02-28","accession":"0001653477-23-000010","full_text":"https://origin.rootz.global/static/filing/0001653477-23-000010.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":32,"context":"onsideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) exceeds $5,000,000.  Material Adverse Effect means a circumstance or condition that has materially adversely affected or would reasonably be expected to materially adversely affect (a) the business, assets, operations or financial condition of","filed_date":"2022-06-24","accession":"0001193125-22-181585","full_text":"https://origin.rootz.global/static/filing/0001193125-22-181585.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":16,"context":"appointment of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for 2022; | | | 3. | Approve, on a non-binding advisory basis, the compensation of the Companys named executive officers; and | | | 4. | Consider any other business properly brought before the meeting. | | How to Vote | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Before the Annual Meeting, vote online","filed_date":"2022-03-11","accession":"0001140361-22-009128","full_text":"https://origin.rootz.global/static/filing/0001140361-22-009128.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":18,"context":"l effects that compliance with these regulations may have upon the capital expenditures, earnings or competitive position of Ingevity, but we currently anticipate that such compliance will not have a material adverse effect on any of the foregoing. Environmental and other regulations and related legal proceedings have the potential to involve significant costs and liability for Ingevity. Intellectual Property Intellectu","filed_date":"2022-02-24","accession":"0001653477-22-000008","full_text":"https://origin.rootz.global/static/filing/0001653477-22-000008.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":13,"context":"ship role in CEO and executive succession planning | | | | | | | | Annual Board and Committee self-evaluations | | | | | | | | Board oversight of key risk areas and risk management program, including cybersecurity related matters | | | | | | | | Enhanced Board oversight of ESG issues and priorities, with oversight responsibility assigned to the Nominating Governance & Sustainability Committee (the NG&S","filed_date":"2021-03-08","accession":"0001140361-21-007642","full_text":"https://origin.rootz.global/static/filing/0001140361-21-007642.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":16,"context":"Reach nominee | | | 18 | | | | | Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm | | | FOR | | | 25 | | | | | Proposal 3: Advisory Vote on Compensation of our Named Executive Officers (Say On Pay) | | | FOR | | | 51 | | | Additional Information For additional information on how to vote and other important matters related to the Annual Meeting, please see pages[54](#tQAAMV) [58](#","filed_date":"2021-03-08","accession":"0001140361-21-007642","full_text":"https://origin.rootz.global/static/filing/0001140361-21-007642.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":26,"context":"e rates and currency devaluation could impair our competitiveness; our operations outside the U.S. require us to comply with a number of U.S. and foreign regulations, violations of which could have a material adverse effect on our financial condition and results of operations; we may be adversely affected by changes in trade policy, including the imposition of tariffs and the resulting consequences; adverse conditions i","filed_date":"2021-02-19","accession":"0001653477-21-000017","full_text":"https://origin.rootz.global/static/filing/0001653477-21-000017.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":33,"context":"onsideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) exceeds $5,000,000.  Material Adverse Effect means a circumstance or condition that has materially adversely affected or would reasonably be expected to materially adversely affect (a) the business, assets, operations or financial condition of","filed_date":"2020-10-28","accession":"0001193125-20-279814","full_text":"https://origin.rootz.global/static/filing/0001193125-20-279814.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":14,"context":"ship role in CEO and executive succession planning | | | | | | | | Annual Board and Committee self-evaluations | | | | | | | | Board oversight of key risk areas and risk management program, including cybersecurity related matters | | | | | | | | Enhanced board oversight of Environmental, Social and Governance (ESG) issues and priorities, with oversight responsibility assigned to the Nominating Governan","filed_date":"2020-03-09","accession":"0001140361-20-005154","full_text":"https://origin.rootz.global/static/filing/0001140361-20-005154.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":21,"context":"each nominee | | | 16 | | | | | Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm | | | FOR | | | 23 | | | | | Proposal 3: Advisory Vote on Compensation of our Named Executive Officers (Say On Pay) | | | FOR | | | 47 | | | Additional Information For additional information on how to vote and other important matters related to the Annual Meeting, please see pages [50](#tQAAMV) [54](","filed_date":"2020-03-09","accession":"0001140361-20-005154","full_text":"https://origin.rootz.global/static/filing/0001140361-20-005154.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_concentration","strength":100,"match_count":1,"context":"of various jurisdictions within North America, South America, Europe, China, Brazil and India, and revenue either directly or indirectly attributable to such government spending continues to remain a significant portion of our revenues. Government business is, in general, subject to special risks and challenges, including: delays in funding and uncertainty regarding the allocation of funds to federal, state and local agencies, del","filed_date":"2020-02-26","accession":"0001653477-20-000014","full_text":"https://origin.rootz.global/static/filing/0001653477-20-000014.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":24,"context":"aterial effects that compliance with these regulations may have upon the capital expenditures, earnings or competitive position of Ingevity, but it is anticipated that such compliance will not have a material adverse effect on any of the foregoing. For a further discussion, see Risk Factors-Risks Related to Ingevitys Business-Our business involves hazards associated with chemical manufacturing, storage, transportation a","filed_date":"2020-02-26","accession":"0001653477-20-000014","full_text":"https://origin.rootz.global/static/filing/0001653477-20-000014.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":4,"context":"come was $7.7 million, $3.4 million, and $2.3 million for the years ended December 31, 2019, 2018 and 2017, respectively. Interest income is primarily related to the interest earned on our restricted investment of $2.0 million and $2.3 million from our fixed-to-fixed cross-currency interest rate swap (see Note 6 and 10 to the Consolidated Financial Statements included in Part II. Item 8 of this Form 10-K for more informati","filed_date":"2020-02-26","accession":"0001653477-20-000014","full_text":"https://origin.rootz.global/static/filing/0001653477-20-000014.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":13,"context":"med in this proxy statement for a one-year term or until his or her successor is duly elected and qualified; | | | | | | | 2. | Approve on an advisory (non-binding) basis the compensation paid to our named executive officers (Say-on-Pay); | | | | | | | 3. | Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019; | | | | | | |","filed_date":"2019-03-11","accession":"0001653477-19-000071","full_text":"https://origin.rootz.global/static/filing/0001653477-19-000071.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_concentration","strength":100,"match_count":1,"context":"he governments of various jurisdictions within North America, Europe, China, Brazil and India, and revenue either directly or indirectly attributable to such government spending continues to remain a significant portion of our revenues. Government business is, in general, subject to special risks and challenges, including: delays in funding and uncertainty regarding the allocation of funds to federal, state and local agencies, del","filed_date":"2019-02-20","accession":"0001653477-19-000011","full_text":"https://origin.rootz.global/static/filing/0001653477-19-000011.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":21,"context":"aterial effects that compliance with these regulations may have upon the capital expenditures, earnings or competitive position of Ingevity, but it is anticipated that such compliance will not have a material adverse effect on any of the foregoing. For a further discussion, see Risk Factors-Risks Related to Ingevitys Business-Our business involves hazards associated with chemical manufacturing, storage, transportation a","filed_date":"2019-02-20","accession":"0001653477-19-000011","full_text":"https://origin.rootz.global/static/filing/0001653477-19-000011.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":4,"context":"facturing. Ingevity operated as a division of Westvaco Corporation and its corporate successors, including MeadWestvaco Corporation and WestRock Company, since 1964. On May 15, 2016, we completed the separation of Ingevity from WestRock Company (WestRock) (herein referred to as the \"Separation\"). The Separation was completed by way of a distribution of all of the then outstanding shares of common stock of Inge","filed_date":"2019-02-20","accession":"0001653477-19-000011","full_text":"https://origin.rootz.global/static/filing/0001653477-19-000011.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":33,"context":"consideration payable in connection therewith (including payment obligations in respect of noncompetition agreements or other arrangements representing acquisition consideration)) exceeds $5,000,000. Material Adverse Effect means a circumstance or condition that has materially adversely affected or would reasonably be expected to materially adversely affect (a) the business, assets, operations or financial condition of","filed_date":"2018-08-09","accession":"0001653477-18-000057","full_text":"https://origin.rootz.global/static/filing/0001653477-18-000057.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":12,"context":"s named in the Proxy Statement, each for a one-year term or until his successor is duly elected and qualified; |  | |  |  2. |  Approve on an advisory basis (non-binding) the compensation paid to our named executive officers (Say-on-Pay); |  | |  |  3. |  Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018; and |  | |  |","filed_date":"2018-03-12","accession":"0001140361-18-012980","full_text":"https://origin.rootz.global/static/filing/0001140361-18-012980.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_concentration","strength":100,"match_count":1,"context":"he governments of various jurisdictions within North America, Europe, China, Brazil and India, and revenue either directly or indirectly attributable to such government spending continues to remain a significant portion of our revenues. Government business is, in general, subject to special risks and challenges, including: delays in funding and uncertainty regarding the allocation of funds to federal, state and local agencies, del","filed_date":"2018-02-28","accession":"0001653477-18-000008","full_text":"https://origin.rootz.global/static/filing/0001653477-18-000008.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":18,"context":"aterial effects that compliance with these regulations may have upon the capital expenditures, earnings or competitive position of Ingevity, but it is anticipated that such compliance will not have a material adverse effect on any of the foregoing. For a further discussion, see Risk Factors-Risks Related to Ingevitys Business-Our business involves hazards associated with chemical manufacturing, storage, transportation a","filed_date":"2018-02-28","accession":"0001653477-18-000008","full_text":"https://origin.rootz.global/static/filing/0001653477-18-000008.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"ai_adoption","strength":100,"match_count":14,"context":"enerally, all employees of Ingevity or its designated subsidiaries who have been employed for at least thirty days will be eligible to participate in the ESPP. The administrator may, prior to the enrollment period for an offering, determine that employees who have been employed less than two years (or a lesser period of time), employees who customarily work twenty hours or less per week, employees wh","filed_date":"2017-03-15","accession":"0001571049-17-002418","full_text":"https://origin.rootz.global/static/filing/0001571049-17-002418.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":31,"context":"compensation for Section 162(m) Internal Revenue Code purposes under the Ingevity Corporation 2016 Omnibus Incentive Plan;  4. Approve on an advisory basis (non-binding) the compensation paid to our named executive officers (Say-on-Pay);  5. Approve on an advisory basis (non-binding) the frequency of advisory votes to approve named executive officer compensation (Say-on-Frequency);  6. Ratify the appointment of Pricewa","filed_date":"2017-03-15","accession":"0001571049-17-002418","full_text":"https://origin.rootz.global/static/filing/0001571049-17-002418.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_concentration","strength":100,"match_count":1,"context":"he governments of various jurisdictions within North America, Europe, China, Brazil and India, and revenue either directly or indirectly attributable to such government spending continues to remain a significant portion of our revenues. Government business is, in general, subject to special risks and challenges, including: delays in funding and uncertainty regarding the allocation of funds to federal, state and local agencies, del","filed_date":"2017-03-02","accession":"0001653477-17-000029","full_text":"https://origin.rootz.global/static/filing/0001653477-17-000029.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"margin_pressure","strength":100,"match_count":14,"context":"similar legislation in the United States and elsewhere may incentivize the use of CTO as a feedstock for production of alternative fuels. Finally, CTO as a raw material may be subject to significant pricing pressures. See Risk Factors - Pricing for CTO is subject to particular pricing pressures by reason of limited supply and competing demands for end use, and we may be limited in our ability to pass on increase","filed_date":"2017-03-02","accession":"0001653477-17-000029","full_text":"https://origin.rootz.global/static/filing/0001653477-17-000029.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":16,"context":"aterial effects that compliance with these regulations may have upon the capital expenditures, earnings or competitive position of Ingevity, but it is anticipated that such compliance will not have a material adverse effect on any of the foregoing. For a further discussion, see Risk Factors - Our business involves hazards associated with chemical manufacturing, storage, transportation and disposal, and Risk Factors - Th","filed_date":"2017-03-02","accession":"0001653477-17-000029","full_text":"https://origin.rootz.global/static/filing/0001653477-17-000029.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":10,"context":"rs identified in 2016 had resulted in the overstatement of pre-tax and net income of $1.6 millionand $1.0 millionin 2015 and $0.9 millionand $0.6 millionin 2014, and a cumulative impact to net parent investment of $2.5 millionas of January 1, 2014. In addition, such errors resulted in the $9.4 millionand $5.5 millionoverstatement of revenue in 2015 and 2014, respectively. Although Ingevitys management has determined that t","filed_date":"2017-03-02","accession":"0001653477-17-000029","full_text":"https://origin.rootz.global/static/filing/0001653477-17-000029.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_concentration","strength":100,"match_count":1,"context":"nments of various jurisdictions within Europe, China, Brazil and India, and we anticipate that revenue either directly or indirectly attributable to such government spending will continue to remain a significant portion of our revenues. Government business is, in general, subject to special risks and challenges, including: delays in funding and uncertainty regarding the allocation of funds to federal, state and local agencies, del","filed_date":"2016-05-03","accession":"0001571049-16-014681","full_text":"https://origin.rootz.global/static/filing/0001571049-16-014681.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":18,"context":"d currency devaluation could impair our competitiveness.  Our operations outside the United States require us to comply with a number of U.S. and foreign regulations, violations of which could have a material adverse effect on our financial condition and results of operations.  Risks Related to Ingevitys Business  We are dependent on attracting and retaining key personnel.  Adverse conditions in the automotive market ma","filed_date":"2016-05-03","accession":"0001571049-16-014681","full_text":"https://origin.rootz.global/static/filing/0001571049-16-014681.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":61,"context":"expiring at the following years annual meeting of stockholders, which Ingevity expects to hold in 2019. Commencing with the first annual meeting of stockholders following the distribution, directors elected to succeed those directors whose terms then expire shall be elected for a term of office to expire at the 2019 annual meeting of stockholders. Beginning at the 2019 annual meeting, all of our directors will stand for election","filed_date":"2016-05-03","accession":"0001571049-16-014681","full_text":"https://origin.rootz.global/static/filing/0001571049-16-014681.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":12,"context":"ion remained unused under the 2022 Authorization.During the three and six months ended June30, 2025, we repurchased no common stock. Note 11: Restructuring and Other (Income) Charges, netDetail on therestructuring charges and other (income) charges, net, is provided below. | | | Three Months Ended June 30, | Six Months Ended June 30, | | | In millions | 2026 | 2025 | 2026 | 2025 | | | | | | | | | Restructuring charges","filed_date":"2026-07-30","accession":"0001653477-26-000047","full_text":"https://origin.rootz.global/static/filing/0001653477-26-000047.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"ai_adoption","strength":96,"match_count":12,"context":"ollows 1.Termination Payment. Ingevity shall make payment in the amount of $100,000,000.00 to Georgia-Pacific (the Termination Payment) by EFT to the account identified on Exhibit A in two equal installments (each an Installment Payment) no later than the dates set forth below (the Payment Due Dates). 1 | | | | | | | | | | | | | Amount | Payment Due Date | | | Installment 1 | $50,000,000.00 | July 1,","filed_date":"2024-07-08","accession":"0001653477-24-000073","full_text":"https://origin.rootz.global/static/filing/0001653477-24-000073.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"NGVT","company":"Ingevity Corp","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":96,"match_count":12,"context":"nd $67.59, respectively.  19 INGEVITY CORPORATION Notes to the Condensed Consolidated Financial Statements June30, 2023 (Unaudited) Note 11: Restructuring and Other (Income) Charges, net Detail on therestructuring charges and other (income) charges, net, is provided below. | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | In millions | 2023 | | 2022","filed_date":"2023-08-03","accession":"0001653477-23-000047","full_text":"https://origin.rootz.global/static/filing/0001653477-23-000047.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."}],"origin":{"leaf":"499528882c26c5f9ba7b7576410b8e3a015d8a638300e83d5a17b776d33ede86","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"5d7bcf19e28117259803cbe0118d3cd5869cf7979d2b32438ac967094a358469","parent":null,"source":"signal_search","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":95,"hourly_limit":500,"remaining":405,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}